Quantum-Si (QSIAW)
0.90
0.20 (28.76%)
At close: Jan 15, 2025, 11:29 AM
Company Description
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).
The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications.
The company was founded in 2013 is headquartered in Branford, Connecticut.
Quantum-Si
| Country | United States |
| IPO Date | n/a |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 159 |
| CEO | Jeffrey Alan Hawkins |
Contact Details
Address: 29 Business Park Drive Branford, United States | |
| Website | https://www.quantum-si.com |
Stock Details
| Ticker Symbol | QSIAW |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001816431 |
| CUSIP Number | n/a |
| ISIN Number | US74765K1135 |
| Employer ID | 85-1388175 |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Jeffrey Alan Hawkins | President, Chief Executive Officer & Director |
| Jeffry R. Keyes CPA | Chief Financial Officer & Treasurer |
| Todd Rearick | Chief Technology Officer |
| Alex A. Hutcheson | Senior Vice President of Sales & Service |
| Dr. Christian Lapointe J.D., Ph.D. | General Counsel & Corporate Secretary |
| Dr. Jonathan M. Rothberg Ph.D. | Founder & Executive Director |
| Johan Denecke | Senior Vice President of Operations |
| John S. Vieceli | Chief Product Officer |
| Juan Esteban Avendano | Vice President of Investor Relations |
| Katherine Atkinson | Senior Vice President of Demand Generation & Corporate Brand |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 10, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Jan 06, 2025 | 8-K | Current Report |
| Jan 06, 2025 | 424B5 | Filing |
| Dec 31, 2024 | SCHEDULE 13D/A | [Amend] Filing |
| Dec 31, 2024 | 4 | Filing |
| Dec 26, 2024 | 4 | Filing |
| Dec 11, 2024 | 8-K | Current Report |
| Dec 11, 2024 | 424B5 | Filing |
| Dec 09, 2024 | 8-K | Current Report |
| Nov 22, 2024 | 8-K | Current Report |